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Unexplained heart failure in a 14-month baby
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Abstract
Endocardial fibroelastosis is a cardiomyopathy rarely seen in the present age. Here, we report a case of 14-months old 
baby who presented with failure to thrive, sweating while feeding, a dilated left ventricle, and left ventricular dysfunction. 
Chest X-ray revealed cardiomegaly with pulmonary venous hypertension. Electrocardiogram showed left ventricular 
hypertrophy with strain pattern. Echocardiogram revealed dilated left ventricle with severe systolic dysfunction which 
was labelled as endocardial fibroelastosis. As there were no associated lesions, it was labelled as primary endocardial 
fibroelastosis (pEFE). The baby was managed conservatively. Here, we would like to highlight the fact that primary en-
docardial fibroelastosis (pEFE) can masquerade as idiopathic dilated cardiomyopathy. Progressive ventricular dilation 
and ventricular dysfunction portends poor prognosis, though few of them may be managed with conservative treatment.
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Introduction
Endocardial fibroelastosis (EFE) is characterized by diffuse 
thickening of the ventricular endocardium and by associa-
ted myocardial dysfunction. It can be primary (idiopathic) 
or secondary to structural heart diseases [1]. In infancy or 
early childhood, this progressive process usually results in 
heart failure. It is primarily a disease of infancy and early 
childhood, with rare occurrences in young adulthood. On 
the basis of left ventricular size, primary EFE can present 
in the more common dilated form or the rarer contracted 
form (with restrictive physiology).
Case report
A 14-months old baby presented with tachypnea, excessive 
sweating, irritability and failure to thrive. His pulse rate 
was 148/min, regular, normovolemic and all pulses were 
palpable without radio-radial or radio-femoral delay. His 
weight was 3.8 kg. Tachypnea while feeding and grunting 
respiration with subcostal and intercostal retractions 
were also noted. He had received all vaccines as per 
immunization schedule. Developmental milestones were 
normal as per his age. On palpation, cardiac impulse 
was hypodynamic. On auscultation, S1 and S2 were faint 
with loud P2 component, a gallop rhythm with an audible 
third heart sound were audible. Routine haemogram was 
normal except mild anaemia. Chest X-ray showed cardio-
megaly with congested pulmonary vascularity (Figure 1). 
Electrocardiogram showed normal axis, tall R-waves, deep 
Q-waves, and T-wave inversion in inferior and left precordial 
leads, suggestive of left ventricular hypertrophy with strain 
pattern (Figure 2). Two-dimensional transrthoracic echocar-
diography showed spherical left ventricular enlargement, 
generalized hypokinesia with systolic dysfunction having 
an ejection fraction of 30%. Septal and free wall were 
557www.journals.viamedica.pl/folia_cardiologica
Santosh Kumar Sinha et al., Unexplained heart failure in a 14-month baby
of collagen and elastic fibres resulting into a pronounced, 
diffuse thickening of the ventricular endocardium resulting 
into myocardial dysfunction. Isolated endocardial fibroela-
stosis resides in the endocardium of a dilated hypertrophied 
left ventricle, which is also known as primary endocardial 
fibroelastosis of the dilated type. It can be secondary to 
various congenital heart diseases, most notably hypopla-
stic left heart syndrome, aortic stenosis, or atresia, patent 
ductus arteriosus, coarctation of aorta, and anomalous left 
coronary artery from pulmonary artery [2–5]. Among the 
two pathological types of primary endocardial fibroelastosis 
i.e. dilated, and restrictive, former is more common. Once 
regarded as a common cause of unexplained heart failure, 
endocardial fibroelastosis is now exceedingly rare.
Fibroelastosis per se is a response to a variety of endo-
cardial stimuli, with intrauterine endocardial injury as the 
common denominator. It may occur in infants and adults 
after myocardial infarction which underscores endocardial 
response to injury. The endocardial thickening is believed 
to be caused by persistent and increased wall tension in 
the ventricles, possibly secondary to damaged myocardium, 
mitral regurgitation, or both. However, endocardial fibroela-
stosis changes are progressive with age.  Primary EFE is the 
type that occurs in infants. Beyond infancy, it is patchy and 
associated with myocardial fibrosis.  The disease is usually 
sporadic, but familial cases have been reported (10%).
Dilated endocardial fibroelastosis is characterized by 
a markedly enlarged globular heart, mainly involving the 
left ventricle (LV) and left atrium (LA). The normal thickness 
of the E of the LV is said to be 0.02 mm at the outflow tract 
and 0.01 mm at the inflow tract [6]. The LV endocardium 
is opaque, glistening, milky white, and diffusely thickened 
to about 1–2 mm. The thickening is most marked in the 
outflow tract. Papillary muscles and trabeculae carneae are 
flattened and partially incorporated in the fibrotic process, 
giving a smooth appearance to the lining of the cavity. They 
exert an undesirable lateral traction on the chordae tendi-
nae and mitral cusps, leading to faulty leaflet opposition 
Figure 1. Chest radiograph, anteroposterior (AP) view, showing 
cardiomegaly and pulmonary venous congestion in a 14-month old 
baby with primary endocardial fibroelastosis (pEFE)
Figure 2. Electrocardiogram showed tall R-waves, deep Q-waves, and T-wave inversion in inferior and left precordial leads, suggestive of left 
ventricular hypertrophy with strain pattern
thickened due to left ventricular hypertrophy. Distinctive 
bright echoes originating from ventricular endocardium 
were also noted. Valvular echoes were normal and shunt 
lesions were ruled out. There was no left ventricular outflow 
obstruction (Figure 3). He was therefore diagnosed as pri-
mary endocardial fibroelastosis (pEFE). He was discharged 
with digoxin, diuretics, and hydralazine (3 mg/kg/day in 
four divided doses) in stable condition with appropriate 
follow up advice.
Discussion
The term endocardial fibroelastosis (EFE) was introduced by 
Weinberg and Himmelfarb in 1943 [1]. It is characterized 
by an opaque, pearly-white thickening due to proliferation 
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diagnostic, although may not be always seen [8]. The abi-
lity of myocardial delayed-enhancement (MDE) by cardiac 
magnetic resonance imaging (MRI) technique to image EFE 
has been reported [8, 9]. Maredia et al. [9] performed MDE 
cardiac MRI on a 17-year old patient with the diagnosis of 
primary EFE where they demonstrated high-signal intensity 
in ventricular endocardium. In patients with secondary 
EFE, cMRI demonstrated hyper enhancement involving 
the endocardial surface of the LV and a hypo intense layer 
at the endocardial surface in the perfusion sequence as 
shown by Stranziger et al. [8] This enhancement is thought 
to be because EFE is avascular; hence, it will appear as 
a low signal in the perfusion sequence [8]. Death usually 
results from heart failure within weeks, usually within the 
first 6 months of life and those who manage to survive, 
more chronic course is common as in our case. Such 
patients respond to medications used to treat congestive 
heart failure. Remissions may rarely be seen with intensive 
medical management. Occasionally, cardiac arrhythmias in 
form of electrical storm may be seen [3]. Early diagnosis 
and prompt persistent administration of digitalis may re-
sult in clinical improvement and reversion of the cardiac 
resulting into mitral incompetence [6]. Although the endo-
cardium is thickened, the ventricular wall (myocardium) 
thickness is within the reference range. Endocardial fibrosis 
acts as a substrate for mural thrombosis, setting a stage 
for systemic emboli. In approximately 50% of patients, 
the mitral and aortic valves are involved, often producing 
marked deformity and either valvular regurgitation or ste-
nosis, although aortic incompetence is very rare. The less 
common contracted type of primary endocardial fibroela-
stosis is associated with a relatively hypoplastic or normal 
LV size. The right and left atria and the right ventricle are 
markedly enlarged and hypertrophied, with minimal or no 
endocardial sclerosis.
Infants who present with acute failure almost always 
die from the acute episode unless they receive a trans-
plant. Patients with a chronic presentation have a 30–40% 
mortality rate due to resistant heart failure. Contracted 
endocardial fibroelastosis has a grave prognosis and is 
generally fatal. Clinical diagnosis of pEFE is difficult be-
cause clinical symptoms, electrocardiographic findings, 
and chest X-ray are usually nonspecific. Echocardiogram by 
showing characteristic endocardial enhancement may be 
Figure 3A–D. Spherical left ventricular enlargement, with thickened septal and free wall. Distinctive bright echoes originating from ventri-
cular endocardium were also noted (white arrow)
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enlargement (CE) to normal. Early and prolonged treatment 
with digoxin is suggested. Continue therapy for several 
years after the symptoms disappear; cessation of drug 
administration may result in acute cardiac failure, even 
when heart size has returned to normal. Other measures for 
acute failure and exacerbations of failure may be required, 
and precipitating factors, such as infection and anaemia, 
require attention. Anticoagulation may be required in the 
presence of thromboembolic complications.
Recently, surgical endocardial resection has been 
performed with left ventricular rehabilitation for patients 
with borderline hypoplastic left heart syndrome and 
secondary EFE [8–12]. The thick endocardial layer in 
EFE is thought to cause mechanical impairment of flu-
id–structure interaction and prevent LV growth. Of note, 
endocardial resection improved LV systolic and diastolic 
performance and relieved the mechanical impairment of 
myocardial function. Recurrence of EFE within the previo-
us resection fields did not occur. If endocardial stripping 
can result in improved function in these structurally 
malformed ventricles, it is reasonable to speculate that 
the same therapeutic benefit might occur in the patients 
with primary EFE without a hypoplastic ventricle. Besides 
potential therapeutic interventions, making the diagnosis 
of EFE clinically would lead to a better understanding 
of the genetics and natural history of this underappre-
ciated entity.
Our case is unusual as pEFE in an older child is rarely 
seen in the era of widespread vaccination. Cases of EFE 
from mumps infection in-utero have become so rare, due 
to the almost universal use of the MMR (measles, mumps, 
and rubella) vaccine, that lack of familiarity and very low 
probability virtually exclude this diagnosis from conside-
ration. Also, cardiac echocardiogram is a sensitive test for 
EFE. Though pEFE is rare, one need to be cognizant that 
it can present as an idiopathic dilated cardiomyopathy.
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Streszczenie
Fibroelastoza wsierdzia jest kardiomiopatią rzadko występującą w XXI wieku. Przedstawiono przypadek 14-miesięcznego 
dziecka, u którego stwierdzono upośledzenie rozwoju, pocenie się podczas karmienia, powiększenie i dysfunkcję lewej 
komory serca. Badanie radiologiczne klatki piersiowej ujawniło kardiomegalię z tętniczym nadciśnieniem płucnym. 
W elektrokardiogramie stwierdzono zmiany typowe dla przerostu lewej komory serca. Badanie echokardiograficzne uwi-
doczniło poszerzoną lewą komorę z ciężką dysfunkcją skurczową, co wskazywało na fibroelastozę wsierdzia. W związku 
z tym, że nie stwierdzono innych zmian, uznano, że jest to pierwotna (idiopatyczna) fibroelastoza wsierdzia (pEFE). Zasto-
sowano leczenie zachowawcze. Należy podkreślić, że pEFE może imitować idiopatyczną kardiomiopatię rozstrzeniową. 
Postępujące powiększanie się lewej komory i nasilanie się jej dysfunkcji wiążą się ze złym rokowaniem, choć niektóre 
takie przypadki poddają się leczeniu zachowawczemu.
Słowa kluczowe: kardiomiopatia, pierwotna fibroelastoza wsierdzia, dysfunkcja skurczowa, kardiomiopatia  
rozstrzeniowa
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